Medigen Vaccine Biologics Corp.

Medigen Vaccine Biologics, a Taiwanese biopharma subsidiary of Medigen Biotech, is advancing a pipeline of Phase‑III vaccines—including COVID‑19, enterovirus A71, and quadrivalent influenza—alongside dengue and RSV candidates, partnered with Dynavax and BlueWillow.

Headquarters: Taiwan (TWN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Family Planning Centers

HQ: Zhubei City

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
6547	Medigen Vaccine Biologics Corp. Cap: 12.2B	EQUITY	TWO	TWD	TW0006547003	Active	📈